Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > It's now time for Soleus Capital Mgmt, L.P.

<< Previous

Bullboard Posts

Next >>

Comment by Mannequinon Dec 09, 2024 10:13am

56 Views

Post# 36352531

RE:RE:RE:RE:It's now time for Soleus Capital Mgmt, L.P.

Dawn should be shown the door

PWIB123 wrote: We haven't even cleared last week's high yet after this fairly excellent news release. The embarrassment lays solely on the leadership team, especially Dawn and Paul. They burned too many people over the last few years. No trust, but this does feel like a big milestone and something that will eventually bridge the gap forward.

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season